Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100047094Phase 4Recruiting
Phase 4, randomised trial of roxadustat in anaemia, diabetic glomerulosclerosis and arterial calcification (2 arms), sponsored by Shanghai Pudong Hospital. Primary endpoint: Hemoglobin. Started Jul 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100047094.